A population-based study of transformed marginal zone lymphoma: identifying outcome-related characteristics

• Published in: Blood cancer journal (New York) Vol. 13; no. 1; p. 130
• Main Authors: Bult, Johanna A. A., Huisman, Francien, Zhong, Yujie, Veltmaat, Nick, Kluiver, Joost, Tonino, Sanne H., Vermaat, Joost S. P., Chamuleau, Martine E. D., Diepstra, Arjan, van den Berg, Anke, Plattel, Wouter J., Brink, Mirian, Nijland, Marcel
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 01.09.2023; Springer Nature B.V; Nature Publishing Group
• Subjects: 631/67/1990/291/1621/1915; 631/67/2324; Biomedical and Life Sciences; Biomedicine; Cancer Research; Hematology; Lymphoma; Mortality; Oncology; Population-based studies
• ISSN: 2044-5385; 2044-5385
• DOI: 10.1038/s41408-023-00903-w

Histological transformation of marginal zone lymphoma (tMZL) into diffuse large B-cell lymphoma is associated with poor outcomes. Clinical characteristics associated with transformation risk and outcome after transformation are largely unknown due to scarcity of data. In this population-based study, competing risk analyses were performed to elucidate clinical characteristics associated with developing transformation among 1793 MZL patients using the Netherlands Cancer Registry. Cox regression analyses were performed to elucidate clinical characteristics associated with risk of relapse and mortality after transformation. Transformation occurred in 75 (4%) out of 1793 MZL patients. Elevated LDH and nodal MZL subtype at MZL diagnosis were associated with an increased risk, and radiotherapy with a reduced risk of developing tMZL. Most tMZL patients received R-(mini)CHOP ( n  = 53, 71%). Age >60 years and (immuno)chemotherapy before transformation were associated with an increased risk of relapse and mortality after transformation. Two-year progression-free survival (PFS) and overall survival (OS) were 66% (95% CI 52–77%) and 75% (95% CI 62–85%) for R-(mini)CHOP-treated tMZL patients, as compared to a PFS and OS both of 41% (95% CI 19–63%) for patients treated otherwise. Our study offers comprehensive insights into characteristics associated with transformation and survival after transformation, thereby optimizing guidelines and patient counseling.